Exploring AI and CAR T Innovations at COAs Practice Event

The Community Oncology Alliance (COA) is set to host its annual “Innovation in Practice” conference, a key event for oncology professionals focused on integrating cutting-edge advancements into community-based cancer care. Scheduled for April 28–29, 2026, in Orlando, Florida, the conference will address critical topics shaping the future of oncology, including artificial intelligence (AI), chimeric antigen receptor (CAR) T-cell therapy, and the challenges of ensuring equitable access to these innovations.

Conference Themes: AI and Next-Generation Therapies

The 2026 COA conference will explore how independent community oncology practices can adopt and optimize emerging technologies to improve patient outcomes. A central focus will be the practical applications of AI in cancer care, from diagnostic tools to personalized treatment planning. According to materials from the conference, AI is expected to play a transformative role in streamlining workflows, reducing administrative burdens, and enhancing clinical decision-making in community settings.

Another major topic is the expansion of CAR T-cell therapy and bispecific antibodies into community oncology practices. These therapies, once limited to academic medical centers, are now being integrated into smaller, independent clinics. The conference will examine the logistical, financial, and clinical considerations of delivering these complex treatments outside traditional hospital systems. Discussions will also cover reimbursement models, patient access strategies, and the role of community practices in expanding clinical trial participation.

Addressing Access and Equity in Cancer Care

A core mission of the COA is to ensure that innovations in cancer treatment reach all patients, regardless of geographic or socioeconomic barriers. The 2026 conference will highlight the disparities in access to advanced therapies, particularly in rural and underserved communities. Independent community oncology practices, which provide care to a significant portion of cancer patients in the U.S., are positioned to bridge this gap—but only if they can overcome systemic challenges such as reimbursement delays, workforce shortages, and regulatory hurdles.

The event will feature sessions on engaging with payers to develop sustainable models for delivering high-cost therapies. Experts will discuss strategies for negotiating with insurance providers, securing funding for innovative treatments, and advocating for policy changes that support community-based care. These conversations are particularly timely as the cost of cancer therapies continues to rise, placing financial strain on both patients and providers.

Health Policy and the Future of Community Oncology

Health policy changes will be another critical focus of the conference. Speakers will address recent and upcoming regulatory shifts that impact how community oncology practices operate, including updates to Medicare reimbursement rules, value-based care initiatives, and efforts to reduce drug pricing disparities. The goal is to equip attendees with the knowledge and tools needed to navigate an evolving healthcare landscape while maintaining high-quality, cost-effective care.

The conference will also provide a platform for oncology leaders to share best practices for implementing new care models. Topics will include the integration of radiation oncology services, the role of pharmacy in managing complex therapies, and strategies for improving patient engagement and adherence. By fostering collaboration among independent practices, the COA aims to create a more unified approach to cancer care that prioritizes both innovation and accessibility.

Who Should Attend?

The COA’s “Innovation in Practice” conference is designed for a broad audience of oncology professionals, including physicians, nurses, practice administrators, pharmacists, and policy advocates. Attendees will have the opportunity to hear from leading experts in the field, participate in interactive workshops, and network with peers facing similar challenges. The event is particularly valuable for those working in independent community oncology practices, where resources may be limited but the need for innovation is acute.

Registration for the conference is currently open, with details available on the official COA conference website. Early registration is encouraged, as the event is expected to draw a large number of participants from across the country.

Why This Conference Matters

The COA’s annual conference serves as a critical forum for addressing the unique challenges faced by community oncology practices. Unlike large academic medical centers, these independent clinics often operate with fewer resources but serve a diverse and widespread patient population. By focusing on “Innovation in Practice,” the 2026 event underscores the importance of bringing cutting-edge treatments and technologies to the communities where most cancer patients receive their care.

The integration of AI, CAR T-cell therapy, and other advanced treatments into community settings has the potential to revolutionize cancer care. However, without careful planning and collaboration, these innovations could exacerbate existing disparities. The COA conference aims to ensure that progress in oncology is both inclusive and sustainable, benefiting patients regardless of where they live or their ability to pay.

As the healthcare landscape continues to evolve, events like the COA conference play a vital role in shaping the future of cancer treatment. By fostering dialogue among providers, payers, and policymakers, the conference helps to create a more equitable and effective system for delivering care to all patients.